Protein ubiquitination and its reverse reaction, deubiquitination, regulate protein stability, protein binding activity, and their subcellular localization. These reactions are catalyzed by the enzymes E1, E2, and E3 ubiquitin (Ub) ligases and deubiquitinases (DUBs). The Ub-proteasome system (UPS) is targeted by viruses for the sake of their replication and to escape host immune response. To identify novel partners of human papillomavirus 16 (HPV16) E6 and E7 proteins, we assembled and screened a library of 590 cDNAs related to the UPS by using the Gaussia princeps luciferase protein complementation assay. HPV16 E6 was found to bind to the homology to E6AP C terminus-type Ub ligase (E6AP), three really interesting new gene (RING)-type Ub ligases (MGRN1, LNX3, LNX4), and the DUB Ub-specific protease 15 (USP15). Except for E6AP, the binding of UPS factors did not require the LxxLL-binding pocket of HPV16 E6. LNX3 bound preferentially to all high-risk mucosal HPV E6 tested, whereas LNX4 bound specifically to HPV16 E6. HPV16 E7 was found to bind to several broad-complex tramtrack and bric-a-brac domain-containing proteins (such as TNFAIP1/KCTD13) that are potential substrate adaptors of Cullin 3-RING Ub ligases, to RING-type Ub ligases implicated in innate immunity (RNF135, TRIM32, TRAF2, TRAF5), to the substrate adaptor DCAF15 of Cullin 4-RING Ub ligase and to some DUBs (USP29, USP33). The binding to UPS factors did not require the LxCxE motif but rather the C-terminal region of HPV16 E7 protein. The identified UPS factors interacted with most of E7 proteins across different HPV types. This study establishes a strategy for the rapid identification of interactions between host or pathogen proteins and the human ubiquitination system. Abbreviations APC/C, anaphase-promoting complex/cyclosome; BTB, broad-complex tramtrack and bric-a-brac; CRL, Cullin-ring ubiquitin ligase; DUB, deubiquitinase; DWD, DBD1-binding W40 protein; Gluc1, Gaussia luciferase fragment 1; Gluc2, Gaussia luciferase fragment 2; Gluc, Gaussia luciferase; GPCA, Gaussia protein complementation assay; HECT, homology to E6AP C terminus; HPV, human papillomavirus; IQR, interquartile range; JAMM, Jab1/mov34/Mpr1 Pad1 N-terminal+; MJD, Machado/Josephin domain; NLR, normalized luminescence ratio; OTU, ovarian tumor protease; PBM, PDZ-binding motif; PPI, protein-protein interaction; PRS, positive reference set; RING, really interesting new gene; RLU, relative luciferase unit; RRS, random reference set; SOCS, suppressor of cytokine signaling; SRF, substrate recognition factor; Ubl, ubiquitin-like; Ub, ubiquitin; UCH, ubiquitin C-terminal hydrolase; UPS, ubiquitin-proteasome system; USP, ubiquitin-specific protease.
Protein ubiquitination and its reverse reaction, deubiquitination, regulate protein stability, protein binding activity, and their subcellular localization. These reactions are catalyzed by the enzymes E1, E2, and E3 ubiquitin (Ub) ligases and deubiquitinases (DUBs). The Ub-proteasome system (UPS) is targeted by viruses for the sake of their replication and to escape host immune response. To identify novel partners of human papillomavirus 16 (HPV16) E6 and E7 proteins, we assembled and screened a library of 590 cDNAs related to the UPS by using the Gaussia princeps luciferase protein complementation assay. HPV16 E6 was found to bind to the homology to E6AP C terminus-type Ub ligase (E6AP), three really interesting new gene (RING)-type Ub ligases (MGRN1, LNX3, LNX4), and the DUB Ub-specific protease 15 (USP15). Except for E6AP, the binding of UPS factors did not require the LxxLL-binding pocket of HPV16 E6. LNX3 bound preferentially to all high-risk mucosal HPV E6 tested, whereas LNX4 bound specifically to HPV16 E6. HPV16 E7 was found to bind to several broad-complex tramtrack and bric-a-brac domain-containing proteins (such as TNFAIP1/KCTD13) that are potential substrate adaptors of Cullin 3-RING Ub ligases, to RING-type Ub ligases implicated in innate immunity (RNF135, TRIM32, TRAF2, TRAF5), to the substrate adaptor DCAF15 of Cullin 4-RING Ub ligase and to some DUBs (USP29, USP33). The binding to UPS factors did not require the LxCxE motif but rather the C-terminal region of HPV16 E7 protein. The identified UPS factors interacted with most of E7 proteins across different HPV types. This study establishes a strategy for the rapid identification of interactions between host or pathogen proteins and the human ubiquitination system.
Introduction
The ubiquitin (Ub)-proteasome system (UPS) is the major pathway of intracellular protein degradation in eukaryotes [1] . Conjugation of Ub to cellular proteins is involved in mechanisms as diverse as control of cell proliferation, DNA repair, cell death, transcription, membrane trafficking, and immune response. The deregulation of ubiquitination has been implicated in human pathologies such as cancer and neurodegenerative and inflammatory diseases. Ubiquitination involves an enzymatic reaction cascade (E1 Ub-activating, E2 Ub-conjugating enzyme, and E3 Ub-ligating enzyme). Ub is covalently conjugated to a lysine residue or (less frequently) at the N-terminal a amino group of the substrate protein. Ubiquitination can be reversed by deubiquitinating proteases (DUB) [2] . The human genome encodes for two E1, 40 Ub-conjugating enzymes (E2), more than 800 E3 Ub ligase components (E3), and around 100 DUB. The E3 Ub ligases are largely responsible for substrate specificity and can be grouped into two main families, homology to E6AP C terminus (HECT)-type and the largest family of really interesting new gene (RING) finger-type Ub ligases [3] . As obligate intracellular parasites, viruses have evolved the capacity to exploit the UPS during their life cycle. Some viruses can encode their own ubiquitination enzymes. Most frequently, viruses divert cellular ubiquitination enzymes to escape host cell defense and to ensure virus propagation, by cell cycle or cell death control [4] .
More than 200 different human papillomavirus (HPV) types have been characterized so far. Based on the sequence of the capsid L1 gene, HPV can be grouped into genera (such as alpha and beta). Most alpha HPVs exhibit a mucosal tropism, whereas most beta HPVs exhibit a cutaneous one. Persistent infection with high-risk mucosal HPV (such as HPV16, HPV18, HPV33) has been implicated in the carcinogenesis of cervical cancers [5] , oropharyngeal cancers [6] , and anal cancers [7] , HPV16 type being the most frequent high-risk mucosal HPV. Beta HPV types (such as HPV5, 8) have been initially identified in skin lesions of patients with epidermodysplasia verruciformis (EV). Upon sun exposure, these lesions can evolve into squamous cell carcinoma. Recently, some evidences have suggested that some beta HPV types (HPV5, HPV8, HPV38) could promote nonmelanoma skin carcinogenesis of non-EV patients [8] .
The oncogenic potential of HPV is based on the immortalizing activities of the E6 and E7 oncoproteins, which target for degradation of the tumor suppressors P53 and RB1, respectively. E6 functions as an adaptor protein to redirect the E6AP/UBE3A HECT Ub ligase to target some cellular proteins such as P53 for proteasome-dependent degradation [9] [10] [11] . On the other hand, one major activity of E7 is the binding to the members of the RB1 family (RB1, RBL1, RBL2) to trigger G1/S progression. HPV16 E7 has been detected in a complex with RB1 and a Cullin 2-based E3 Ub ligase [12] and has been shown to interact with the substrate recognition factor (SRF) Zer1 protein for RB1 degradation [13] . The half-life of HPV E6 and E7 proteins is also highly regulated, as both proteins are polyubiquitinated and degraded by the proteasome [14, 15, 16] , while the DUBs Ub-specific protease 15 (USP15) and USP11 have been shown to stabilize E6 and E7, respectively [17] and [18] .
Here, we have used the split Gaussia princeps luciferase protein complementation assay (GPCA) [19] to detect direct binary complexes between HPV16 E6 or E7 proteins and the UPS. For this purpose, we have assembled a library covering 50% of the entire human ubiquitination system. The library was screened against HPV16 E6 and E7 proteins and allowed us to identify novel UPS partners. We have also identified the motif/domain within HPV16 E6 and E7 proteins required for the UPS interactions. Finally, we compared the binding to the UPS factors between E6 and E7 proteins across six different HPV types.
Results

Assembling the UPS library
First, a library of cDNAs encoding for UPS factors was assembled from the ORFs encoding UPS factors present in the human ORFeome collection (CCSB, Dana-Farber Cancer Institute). We selected cDNAs encoding UPS factors (E1, E2, E3, DUB), to which we added cDNAs encoding for proteins of the Fanconi anemia complex (FA complex), the anaphase-promoting complex/cyclosome (APC/C), and some UPSrelated proteins. In total, 590 cDNAs encoding for 575 unique protein entries were cloned in the pSPICA-N1 vector by Gateway cloning (Table 1 ). All cDNAs are flanked by attB1 recombination sites and are then easily transferred to any other compatible expression vectors. The pSPICA-N1 vector allows the expression of the UPS factor in fusion with a fragment of the G. princeps luciferase that can be used for the split G. princeps protein complementation assay (GPCA) [19] . All cDNA constructs of the library were fully sequenced and annotated. The resulting UPS library comprises five E1 or E1-like proteins, 28 E2-conjugating enzymes, 432 E3 Ub ligase components, three Ub or Ub-like proteins, 63 DUB, 13 proteins of the APC/ CDC complex, and 31 UPS-related proteins (Fig. 1) . The largest protein class corresponds to E3 Ub ligases, with 14 HECT Ub ligases, 189 RING Ub ligases, and 230 potential components of Cullin-based RING Ub ligases (CRL). This last group includes (i) five Cullin proteins (Cullin 2, 3, 4A, 4B, and 5), (ii) 107 broadcomplex tramtrack and bric-a-brac (BTB) domain proteins that can be SRF of Cullin 3-based Ub ligases (CRL3), (iii) 55 F-box proteins that are part of Cullin 1-based Ub ligases (CRL1), (iv) 27 suppressor of cytokine signaling (SOCS) box proteins that interact with Elongin B and C and are part of Cullin 5-based Ub ligases (CRL5), (v) 28 DBD1-binding W40 protein (DWD)-containing proteins that bind DDB1 and act as SRFs of Cullin 4-based Ub ligases (CRL4). The DUB family is represented by 39 USP-, eight ovarian tumor protease (OTU)-, eight Jab1/mov34/Mpr1 Pad1 N-terminal+ (JAMM)/MPN-, four Ub C-terminal hydrolase (UCH)-, three Machado/Josephin domain (MJD)-containing DUBs. The Ub and ubiquitin-like (Ubl) Conjugation Database (www.uucd.biocuckoo. org) has recently annotated and classified human UPS effectors according to the presence of motif/domain signature [20] . By comparison to this database, the current version of our UPS library contains 55% of the E1 and E1-like proteins, 73% of the E2-conjugating enzymes, 100% of the APC/CDC complex, 48% of the HECT Ub ligases, 42% of the RING finger Ub ligases, 44% of the Cullin-based Ub ligases (75% of BTB domain proteins, 93% of F-box proteins, 66% of SOCS proteins, and 10% of DWD domain proteins), and 51% of DUB. The current UPS library covers around 50% of the entire human ubiquitination system.
Screening of the UPS library against HPV16 E6 and E7 proteins
We used GPCA to perform a systematic unbiased screening for binary interactions between viral proteins and the UPS. The UPS library was screened against HPV16 E6 and E7 proteins. In a different work, the UPS library was also screened against the PB2 proteins of human influenza viruses (Biquand E. et al. manuscript in preparation). Briefly in GPCA, the luciferase activity is restored leading to luminescence signal when the two fragments of the Gaussia luciferase are in close contact resulting in the interaction between the prey and the bait fused to Gaussia luciferase fragments 1 and 2 (Gluc1 and Gluc2), respectively. To verify that the GPCA discriminates between positive and negative interactions, HPV16 E6 and E7 proteins were screened against (a) a random reference set (RRS) containing nine proteins supposedly nonbinder proteins and (b) a positive reference set (PRS) containing wellestablished binding partners (including E6AP [9] , hADA3 [21] , MAGI-1 [22] , SCRIB [23] , DLG3 [24] , an homolog of DLG1 [25] , IRF3 [26] for E6 and RB1 [27] , RBL1 [28] , EEF1A1 [29] , PKM2 [29] , PTPN14 [30] for E7). The GPCA signals obtained with the PRS were significantly higher than the ones obtained with RRS (Fig. 2, Table S1 ).
Then, we estimated the 'background' GPCA signal of the UPS library. For this purpose, the UPS library containing 590 Gluc1-fused UPS proteins was tested against the complementary Gluc2 fragment alone. The vast majority of constructs gave a weak GPCA signal. Representation of frequency as a function of the log10 of the luminescence values using a Kernel density (KDE) plot function results in a nearly normal distribution (Fig. 3A) . The small shoulder on the right side of the distribution curve at 4.2 corresponds to 26 Gluc1-UPS factors/Gluc2 protein pairs including Gluc1-TRAF3IP2, which gives an exceptionally high luminescence value (Table S2) . Given their high background signals, these 26 Gluc1-UPS proteins should be considered with high precaution when tested with a Gluc2-fused bait.
Each screen of the UPS library with either HPV16 E6 or E7 has been performed in a single transfection experiment, thus allowing for the assessment of the entire UPS library at once. A small fraction of UPS factors generated 'outlier' luminescence values (see the shoulders on the right of the curve) by comparison to noninteracting pairs (which is the case for the majority of the UPS factors; Fig. 3B,C) . Thus, here we considered as potential interacting pairs, those with a GPCA signal above a standard threshold (T) on a Whisker plot representation. In this way, we found 81 and 65 outlier luminescence values for the E6 and E7 proteins, respectively (Fig. 3D-E and Table S3 ).
Retesting protein pairs by GPCA
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Validation of protein pairs by coimmunoprecipitation
We tested all the potential interacting protein pairs detected by the GPCA approach by using an orthogonal co-immunoprecipitation (IP) experiment. In this case, the Gaussia-tagged UPS factors were coexpressed with FLAG-tagged viral bait (E6, E7) in HEK293T cells. The protein complexes were purified using ANTI-FLAG beads and analyzed by gel electrophoresis and western blot using anti-Gaussia luciferase antibody. This low-throughput interactomic approach allowed us to consolidate some of the protein-protein interactions (PPI) identified by the GPCA. We selected UPS factors with an IP ratio > 3 (i.e., Flag-E6/Ctrl and Flag-E7/Ctrl ratio in Fig. 4 , Table S9 ). We observed a strong association of E6 with the Ub ligases E6AP, LNX3, and LNX4 (IP ratio > 5) and a more modest one with MGRN1 and USP15 (Fig. 4A ). For E7, we observed strong interactions with the RING Ub ligases NEURL1 and RNF135, the BTB domain protein TNFAIP1, the WD40-containing protein DCAF15, and the DUBs USP26, USP29, USP33 (IP ratio > 5). Weaker interactions were instead observed between E7 and the RING Ub ligases (TRAF2, TRAF5, TRIM32, TRIM72), the BTB domain proteins (BTBD15, KCTD13, ZBTB9, ZBTB32, SHKBP1, ZBTB48), and the DUB MPND (Fig. 4B) .
Identification of the domain/motif interactions implicated in UPS targeting by E6 and E7
The HPV16 E6 contains two zinc-binding domains and a PDZ-binding motif (PBM) at its COOH terminus. The structure of HPV16 E6 in complex with a peptide from UBE3A/E6AP revealed the presence of a charged hydrophobic pocket in E6 hosting the LxxLL motif [10] . We verified the expression of E6 mutants (E6 L50E containing a mutation within the LxxLLbinding pocket and E6DPBM containing a deletion of Log10 (luminescence) (RLU) P < 0.001 P < 0.001 Fig. 2 . GPCA signal of HPV16 E6 and E7 proteins tested against the proteins of the PRS and the RRS. HEK293T cells were cotransfected with plasmids encoding Gluc2-16E6 or Gluc2-16E7 and the Gluc1-RRS proteins or Gluc1-PRS. The PRS was composed of UBE3A/E6AP, hADA3, MAGI-1, SCRIB, DLG3, IRF3 for E6 and EEF1A1, PKM2, PTPN14, RB1, RBL1 for E7. Twenty-four hours after transfection, the cells were lysed and the luciferase activity was measured. The log10 of the luminescence value for each protein pair is represented as a dot, and the median as a black line. Statistical analysis was performed with two-tailed t-test with unequal population variances (P < 0.001).
the last four amino acids inhibiting the binding to PDZ domain-containing proteins) by western blot (Fig. 5A) . We tested E6 L50E and E6ΔPBM mutants against all UPS factors validated by co-IP using the GPCA (Fig. 5B , Table S5 ). The E6 L50E was unable to interact with E6AP as expected, but it was still able to interact with LNX3, LNX4, and MGRN1. For USP15, the GPCA signals obtained with wild-type or mutant E6 proteins were too weak to allow us to conclude on the impact of the mutation. E6ΔPBM was unable to bind MAGI-1 but it could still interact with LNX4, MGRN1, and E6AP. The deletion of the PBM also inhibited the binding of E6 to LNX3, which is consistent with previous reports that LNX3/E6 interaction requires the PBM of E6 [31] . Surprisingly, the E6ΔPBM was still able to interact with our construct of LNX4 that corresponds to isoform 2. The E7 protein contains three regions: the unfolded CR1 and CR2 regions (the latter one containing the LxCxE motif required for RB1 interaction [32] ) and the C-terminal region containing a zinc-binding domain [33] . We analyzed by western blot the expression of the three constructs of HPV16 E7: the CR1 + CR2 region (1-36 amino acids), the C-terminal region (37-98 amino acids), and the HPV16 E7 C24G/E26G construct mutated within the LxCxE motif (Fig. 6A) . We noticed that at the protein level the Gluc2-CR1 + CR2 construct was lower than the Gluc2-C-terminal construct of E7. As the CR1 and CR2 regions are intrinsically disordered [34] , the construct Gluc2-CR1 + CR2 is maybe less expressed or more prone to aggregation/ degradation.
The E7 constructs were tested against all selected UPS factors by GPCA and co-IP ( Fig. 6B ; Table S6 ). As expected, we confirmed that the interaction between HPV16 E7 and RB1 or RBL1 requires the integrity of the LxCxE motif within the CR2 region [29] . Indeed, we observed that the C24G/E26G mutations inhibited completely the binding to RB1 and, to some extent, the binding to RBL1. This observation Screening of the UPS library with Gluc2, Gluc2-16E6, and Gluc2-16E7 by using GPCA. HEK293T cells were cotransfected with plasmids pSPICA-N1-UPS encoding Gluc1-UPS and the pSPICA-N2, pSPICA-N2-16E6, pSPICA-N2-16E7 encoding Gluc2, Gluc2-16E6, Gluc2-16E7. Twenty-four hours after transfection, the cells were lysed and the luciferase activity was measured. The log10 of the luminescence values of Gluc1-UPS factors tested against Gluc2 (A), Gluc2-16E6 (B), or Gluc2-16E7 (C) are represented according to the frequency in the KDE plot representation. On the curve, the dashed line indicates the position of the 'shoulder' (cutoff value). Whisker plot representation of the luminescence values of Gluc1-UPS factors tested against Gluc2-16E6 (D) and Gluc2-16E7 (E). The outlier luminescence values (circles) fall above the threshold T = Q3 + 1.5xIQR.
suggests that there are potential additional binding sites for RBL1 in HPV16 E7. In contrast, the mutation of the LxCxE motif did not affect the binding to the UPS factors. The GPCA signals obtained with RB1 or RBL1 and with the CR1 + CR2 construct were not as high as the ones obtained with the full-length E7 protein, possibly due to the lower expression and/or stability of the CR1 + CR2 construct. The association with PTPN14 was mediated by the C-terminal region of E7 as previously reported [30] . All UPS factors seem to interact with the C-terminal region of E7, albeit at different extents. For some UPS factors (such LNX3   LNX4  MGRN1  E6AP  USP15   I  I  IP  IP  I  I  IP  IP  I  I  IP  IP  I  I  IP  IP  I  I  IP Fig. 4 . Co-IP of UPS factors with HPV16 E6 and E7 proteins. HEK293T cells were cotransfected with pCineo-3xFLAG-16E6 (A), pCineo3xFLAG-16E7 (B), or empty vector (À) and pSPICA-Gaussia-UPS encoding UPS proteins fused to Gaussia protein. RBL1 was also used as a positive control. Lysates were incubated with anti-FLAG magnetic beads. Total proteins (20% input, IN), and IP proteins were analyzed by western blot by using anti-Gluc antibodies. Protein band intensities were quantified using IMAGE J software (open source, Wayne Rasband, NIH) (Table S9 ). Band intensities in the IP lanes were normalized according to intensities in the input lanes. For each Gluc-UPS protein, we calculated the IP (E6 or E7)/IP (Ctrl) ratio, where IP (E6 or E7) corresponds to the normalized intensity in the E6 or E7 IP lane and IP (Ctrl) corresponds to the normalized intensity in the control IP lane. UPS factors with an IP ratio < 3 are not represented (data not shown). Note: For LNX3, NEURL1, TRAF5, TRIM32, TRIM72, SHKBP1 blots, samples were run on the same gel but intervening lanes were removed as indicated in the figure. as TNFAIP1 and USP33), we observed a weak binding for the isolated C-terminal region, suggesting that these interactions required the entire folded E7 protein.
FLAG-E7 quantification IP E7/IP Ctrl
Binding of UPS factors to E6 or E7 from different HPV types
We analyzed the binding profiles of validated UPS factors with E6 and E7 proteins from high-risk mucosal HPV (HPV16, HPV18, HPV33 ), low-risk mucosal HPV (HPV6), and cutaneous HPV (HPV8, HPV38) types by GPCA. The expression of E6 proteins (Fig. 7A ) and E7 proteins (Fig. 8A ) from these different HPV types was verified by western blot. We observed some slower-migrating bands for E6 proteins from HPV16, HPV18, and HPV33 types, which likely correspond to E6* produced from the splicing of the intronic sequence within the E6 gene. To estimate the background GPCA signal produced by the different E6 and E7 proteins, the RRS was also assessed against each protein (Figs 7B and 8B; Tables S7 and S8) . We observed that the E7 proteins from HPV6, HPV8, and HPV38 gave higher NLR values with the RRS than the E7 proteins from HPV16, HPV18, and HPV33 types. We thus considered an interaction to be positive if the NLR of the protein pair was above the upper limit of the confidence interval calculated from the RRS for each E6 or E7 protein of the different HPV types.
We confirmed that E6AP is targeted by E6 from high-risk and low-risk mucosal HPV, whereas MAGI-1 and SMAD3 are specific targets of E6 from high-risk mucosal HPV and cutaneous HPV, respectively, as previously published [29] (Fig. 7C , Table S7 ). Considering the UPS factors, USP15 and MGRN1 interacted ) were transfected with pSPICA-N2-16E6, pSPICA-N2-E6 L50E, and pSPICA-N2-E6ΔPDZ plasmids and pEGFP-C3 plasmid as internal control. The cleared cellular lysates were analyzed by western blot using anti-Gluc, anti-actin, and anti-GFP antibodies. (B) HEK 293T (28 9 10 3 ) cells were transfected with pSPICA-N2-E6 and pSPICA-N1-MAGI-1, pSPICA-N1-SMAD3, and pSPICA-N1-UPS. After transfection, the Gaussia luciferase activity was measured.
Representative NLR values for each protein pair are shown. 18E6  33E6  6E6  8E6  38E6  16E6  18E6  33E6  6E6  8E6  38E6  16E6  18E6  33E6  6E6  8E6  38E6   16E6  18E6  33E6  6E6  8E6  38E6  16E6  18E6  33E6  6E6  8E6  38E6  16E6  18E6  33E6  6E6  8E6  38E6  16E6  18E6  33E6  6E6  8E6  38E6   15 RRS   16E6  18E6  33E6  6E6  8E6  38E6  16E6  18E6  33E6  6E6  8E6 pSPICA-N2-16E6, pSPICA-N2-18E6 pSPICA-N2-33E6, pSPICA-N2-6E6, pSPICA-N2-8E6 or pSPICA-N2-38E6 plasmids, and pEGFP-C3 plasmid as internal control. The cleared cellular lysates were analyzed by western blot using anti-Gluc, anti-actin, and anti-GFP antibodies. HEK293T cells (28 9 10 3 ) were cotransfected with plasmids pSPICA-N1-MAGI-1, pSPICA-N1-SMAD3, pSPICA-N1-RRS, pSPICA-N1-UPS and pSPICA-N2-16E6, pSPICA-N2-18E6, pSPICA-N2-33E6, pSPICA-N2-6E6, pSPICA-N2-8E6, or pSPICA-N2-38E6. (B) NLR values representing the upper limit of the confidence interval calculated for the different E6/RRS pairs. (C) Representative NLR values for interaction between E6 proteins and MAGI-1, SMAD3, and UPS factors. The boxes are colored in blue (positive interaction) when the NLR was above the upper limit of the confidence interval defined with RRS. (D) HEK293T cells were cotransfected with pCineo3xFlag-16E6, pCineo-3xFlag-18E6 or pCineo-3xFlag-33E6, and pSPICA-N1-E6AP. The lysates were incubated with anti-FLAG magnetic beads. Total proteins (input) and IP proteins were analyzed by western blot by using anti-Gluc antibody and anti-Flag antibody. Note: The E6 proteins migrate at the same size than the light chain of immunoglobulins in the IP samples. 16E7  18E7  33E7  6E7  8E7  38E7   RNF135   DCAF15   ZBTB32   16E7  18E7  33E7  6E7  8E7  38E7   16E7  18E7  33E7  6E7  8E7  38E7   16E7  18E7  33E7  6E7  8E7  38E7   30 with E6 proteins from all the tested HPV types, whereas interactions with LNX4 were restricted to HPV16. In contrast, the interaction with LNX3 was strong with E6 proteins from high-risk mucosal HPV types. The high GPCA signal obtained with HPV33 E6 and E6AP is likely to be a consequence of its higher expression by comparison to HPV16 and HPV18 E6 proteins. Indeed, E6AP was equally IP by HPV16, HPV18, or HPV33 E6 proteins (Fig. 7D) . For E7 proteins, we found a difference in the strength of binding to RB1 and RBL1 (Fig. 8C , Table S8 ). The binding of E7 proteins from HPV6 and HPV38 with RB1 was much weaker than for E7 proteins from high-risk mucosal HPV types. In our assay, the HPV8 E7 did not seem to interact with RB1. In contrast, we observed an interaction between RBL1 and all E7 proteins. Nevertheless, the association appeared stronger with high-risk mucosal HPV E7 proteins. The phosphatase PTPN14 was able to interact with all E7 proteins as previously published [30] . We observed a positive interaction for all E7 proteins with the RING-type Ub ligases (NEURL1, TRAF5, TRIM32), the BTB-containing proteins (TNFAIP1, KCTD13, ZBTB9, ZBTB32, ZBTB48, SHKBP1), and the DUB USP33.
Discussion
We used the split G. princeps luciferase protein complementation assay (GPCA) to identify interactions between HPV E6 and E7 proteins and effectors of the UPS. Here, GPCA is used for the first time as a PPI screening approach and not just as a validation assay [29, 35] . GPCA is a sensitive unbiased approach (in which each potential interacting protein is equally overexpressed in the mammalian cell), complementary to the most popular interactomic methods, namely yeast two-hybrid and AP/MS. GPCA mostly detects direct binary interactions. Indeed, the protein pair HPV16 E6 and P53, which interacts via E6AP, gave no GPCA signal (data not shown). This is probably due to the fact that cellular E6AP protein level is not sufficiently high to bridge the overexpressed Gluc2-E6 and Gluc1-P53.
We assembled and screened a UPS library consisting in 590 cDNAs encoding human proteins and covering about 50% of the human ubiquitination system. To minimize the selection of nonspecific interactions, we adopted a stepwise GPCA-based screening strategy. First, we measured luminescence values for all Gluc1-UPS constructs in the presence of the Gluc2 fragment, in order to determine the 'background' GPCA signal. We found that only few Gluc1-fused proteins (mainly TRAF3IP2 and UBB) produced a high level of background GPCA signal. Interestingly, these proteins did not co-IP with either E6 or E7, arguing that they might be some false positives of the GPCA. Of note, this determination of the 'background' signal of each UPS factor will serve for any further screening of the UPS library. Second, the potential interacting pairs issued from the first global screen were retested in a second round of GPCA experiment. Third, we tested the HPV E6 and E7 proteins against supposedly noninteracting proteins from a RRS set, which enabled the calculation of a confidence interval. Hence, a protein pair was considered as interacting if the NLR was above the upper limit of the confidence interval calculated for the RRS set. Fourth, we used co-IP as an orthogonal approach to confirm some PPIs detected by the GPCA approach. About 25% of the targets identified in the second round of GPCA experiments were validated as strong binding partners by co-IP. This overlap score for PPI methods is in the same range of what has been reported in a previous study, in which only 25% of well-documented positive interactions have been detected by a single assay and not by the four other interactomic approaches [36] .
In our assay, the G2 tag was fused to the N terminus of E6 and E7 proteins. Indeed, the position of the tag might interfere with protein interaction. It is known that tagging E6 at its C terminus inhibits its interaction with PDZ domain proteins, whereas tagging E7 at its N terminus suppresses binding to UBR4 [37] . Thus, ideally, screening should be performed twice with both N-and C-terminal tagged bait protein.
To be able to place our findings in the biological context, we searched in the Genotype Tissue Expression resource (Gtex Project, www.gtexportal. org) for the expression of all the selected UPS factors and we found that these factors are expressed to some extent in most tissues, in particular tissues that are relevant to HPV biology (cervix, esophagus mucosa, vagina, skin). Only TRIM72, USP26, and USP29 seem to be highly expressed in skeletal muscle and testis, respectively.
In our screen, we recovered known partners of E6 such as UBE3A/E6AP, USP15, and LNX3, arguing in favor of the validity of our strategy. We identified two novel RING Ub ligases (MGRN1 and LNX4). Mainly, two modes of interaction have been described for HPV16 E6: capture of cellular LxxLL motifs, via an hydrophobic pocket and binding to PDZ domains, via its C-terminal PDZ-binding motif (PBM). We found that LNX3, LNX4, USP15, and MGRN1 proteins bind equally well to the wild-type and L50E E6 proteins, showing that these interactions are not mediated via LxxLL recognition. Consistently, we could not detect any LxxLL motif in predicted exposed regions of these proteins (data not shown). Interestingly, binding to USP15 and MGRN1 was common to E6 from all the six HPV types tested. The binding to LNX3 was instead dependent on PDZ/PBM interaction. As expected, LNX3 interacted preferentially with high-risk mucosal HPV E6 proteins (HPV16, HPV18, HPV33). Concerning the E6/LNX4 interaction, we previously suggested that it proceeds via the PDZ1 domain of LNX4, which recognizes the PBM of E6 [24] . However, here, we showed that also isoform 2 of LNX4, which lacks the PDZ1 domain, could interact with E6 via a mechanism that is independent of the PBM motif and specific to HPV16 E6.
We found that the HPV16 E7 protein binds to seven BTB domain-containing proteins (BTBD15, KCTD13, TNFAIP1, SHKBP1, ZBTB9, ZBTB32, and ZBTB48) among the 107 present in the UPS library. The functions of these BTB proteins are largely unknown but some of them are identified substrate adaptors of some Cullin 3-RING Ub ligases such as TNFAIP1 and its homolog KCTD13 [38] . This is in agreement with a previous mass spectrometry-based proteomic analysis showing that E7 proteins were associated with Cullin 3-protein complexes [13] . In our screen, the GPCA signal for E7 and Cullin 3 (that is not NEDDylated in our assay) was very low, suggesting that the two proteins did not interact directly but probably via some BTB proteins. Some of BTB proteins contain also a C2H2-type zinc finger (ZBTB9, ZBTB32, BTBD15, ZBTB48) frequently associated with transcriptional activation. This is consistent with the role of E7 as a main regulator of transcription [39] . The E7 interactions with BTB domains should be further characterized by biochemical and structural approaches.
The HPV16 E7 protein was also shown to bind to (a) RING finger Ub ligases implicated in innate immunity, such as RNF135 [40] , TRAF2 [41] , TRAF5 [42] , TRIM32 [43] , (b) the RING finger Ub ligase NEURL1 implicated in Notch signaling [44] , (c) the substrate adaptor DCAF15 of Cullin 4-DDB1-RING Ub ligase (CRL4) [45] , (d) the DUBs USP26, USP29, and USP33. In contrast to the pocket protein family (RB1 and RBL1), the UPS factors interacting with E7 did not target the LxCxE motif. The C-terminal region of HPV16 E7 protein appeared to interact with all UPS factors albeit at different extents.
We found that most of the identified UPS factors bind to E7 proteins across the different HPV types, in contrast to E6 proteins, which display a more specific binding profile according to HPV types.
Human papillomavirus E6 and E7 proteins can hijack some host Ub ligases and DUBs by redirecting them to novel substrates. The best example is the rewiring of E6AP by E6 to novel substrates such as P53 [11] and Scribble [23] . On the other hand, by interacting with some Ub ligases or DUBs, E6 and E7 proteins might interfere with the ubiquitination of their cellular substrates. Up to now, only few substrates of Ub ligases and DUBs have been clearly identified. The DUB proteins are expected to have a much broader substrate specificity as they are eightfold less abundant. USP15 appears to have many different substrates, among them HPV16 E6 itself [17] , the Ub ligases TRIM25 [46] , and MDM2 [47] . USP29 has been involved in the stabilization of the p53 protein [48] and the checkpoint activator claspin [49] . This latter substrate appears consistent with previous observation showing that HPV16 E7 induces premature degradation of claspin, attenuating the DNA damage checkpoint [50] . USP33 regulates centrosome biogenesis by stabilizing the centriolar protein CP110 [51] and controls the switch between autophagy and innate immune responses by stabilizing RAL-B protein [52] .
Analysis of the interactomes of E6 and E7 with UPS revealed that two major cellular pathways are targeted: the p53 and the innate immune pathways. Indeed, p53 is polyubiquitinated by E6AP/E6 [9] , TRIM32 [53] and stabilized by USP29 [48] . Ubiquitination and especially nondegradative types of poly-Ub chains (such as K63-linked polyubiquitin chains) are known to regulate the innate immune-sensing pathways [54] . Viral RNA species are detected in the cytosol of infected cells by RIG-1 which is activated by K63-linked polyubiquitination mediated by RNF135 [40] and TRIM25 [55] , which is a substrate of USP15 [46] . Sensing of intracellular viral DNAs is mediated by the cGAS/STING pathway. The signaling activity of STING is controlled by K63-linked ubiquitination mediated by TRIM32 [43] . Interestingly, HPV18 E7 has recently been found to interact with the STING protein [56] . The interplay between E7/STING and TRIM32 will require further investigation.
In conclusion, we assembled a library of ORFs encoding UPS factors and described a robust screening strategy to identify direct binary interactions with the UPS. We provide a first characterization of the mechanisms of E6-E7/UPS interactions and of their conservation across the different families. We believe that our systematic interactomic approach will facilitate the deciphering of the Ub system landscape for any further pathogen or host factors.
Materials and methods
DNA constructs
GPCA vectors pSPICA-N1 and pSPICA-N2 (both derived from the pCiNeo mammalian expression vector), respectively, express the Gluc1 and Gluc2 complementary fragments of the G. princeps luciferase linked to the N-terminal ends of tested proteins by a flexible hinge polypeptide of 20 amino acid residues.
The ORFs encoding for the E6 and E7 proteins from HPV16 were amplified by PCR and cloned into vector pDONR207 by recombination cloning (Gateway system; Invitrogen, Carlsbad, CA, USA). The resulting entry clones were then transferred into Gateway-compatible GPCA destination vector pSPICA-N2.
The ORFs encoding UPS factors were obtained from the Human ORFeome collections v3.1, 5.1, 7.1, and 8.1 (CCSB, Dana-Farber Institute, Boston, MA, USA) as entry clones into the pDONR223 or pDONR207 vector. They were transferred into the destination vector pSPICA-N1 by Gateway cloning. The resulting pSPICA-N1-UPS plasmids were sequenced in both directions by using forward primer (5 0 -CAGCTCTTAAGGCTAGAGTAC-3 0 ) and reverse primer (5 0 -CACTGCATTCTAGTTGTGGTTTGTCC-3 0 ). The sequences were compared to the human genome by performing a blast search to identify the cDNA and the isoform when it is known ( Table 1 ). The presence of truncation or mutation was annotated and the in-frame fusion with the Gluc1 fragment of Gaussia luciferase was verified. The RRS contains human ORFs encoding proteins randomly picked from the human ORFeome and a priori not interacting with the viral proteins [57]: LRCC28, NXP2, NFE2L1, GSTT1, GYPA, UGT3A1, DBH, PLEKHA9, NXPH1. The PRS contains human ORFs encoding a fragment of E6AP (291-875 amino acids) [9] , hADA3 [21] , MAGI-1 [22] , SCRIB [23] , DLG3 [24] , an homolog of DLG1 [25] , IRF3 [26] for E6 and EEF1A1 [29] , PKM2 [29] , PTPN14 [30] , RB1 [27] , RBL1 [28] for E7. The PRS and RRS ORFs were cloned into the pSPICA-N1 vector. Results were expressed as relative luciferase activity (RLU) or as a fold change normalized over the sum of controls, specified herein as NLR. For a given protein pair A/B, NLR = (Gluc1-A + Gluc2-B)/[(Gluc1-A + Gluc2) + (Gluc1 + Gluc2-B)]. Cassonnet et al. used an interaction matrix consisting of human proteins of the NFjB and interferon signaling pathways and determined that a cutoff of 3.5 for NLR discriminates interacting pairs from noninteracting pairs with a false-positive background below 2.5% [19] . For the NLR validation experiment, each protein pair was assessed three times or more. The NLR of protein pair was considered as 'validated' if above a threshold value of 3.5 and above the upper limit of the confidence interval defined for the RRS/bait pairs.
Cell line
UPS library screening using GPCA
For Gluc2, Gluc2-16E6, and Gluc2-16E7, the entire UPS library was screened in one experiment. The distribution of raw luminescence values was represented by KDE plot and Whisker plot. In the latter representation, the median and the interquartile range (IQR) were calculated allowing the selection of outliers.
Expression of HPV E6 and E7 proteins and coimmunoprecipitation experiment
HEK293T cells (in six-well plate) were cotransfected with 1.8 lg of pSPICA-N2-E6 or pSPICA-N2-E7 and 0.2 lg of pEGFP-C3 as an internal transfection efficiency control. After transfection, cells were harvested and lysed in 100 lL of lysis buffer (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% TRITON X-100, and cocktail proteases inhibitors). After centrifugation at 16 000 g for 20 min at 4°C, the cellular lysates were analyzed by gel electrophoresis and western blot using anti-Gaussia antibody (NEB, Ipswich, MA, USA E8023S), anti-actin antibody (SigmaAldrich, Saint-Louis, MO, USA A2066), and anti-GFP antibody (Roche, Basel, Switzerland).
The E6-and E7-coding sequences were cloned into the pCineo-3xFLAG vector allowing expression of the respective proteins with a Nter-3xFlag tag. HEK-293T cells (in six-well plates) were transfected with 1 lg of plasmid Flag-E6, Flag-E7, or empty vector and 1 lg of plasmid expressing UPS factors fused to the Gaussia protein. Cells were harvested after 24 h and lysed by adding 100 lL of lysis buffer (50 mM Tris/ HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% TRITON X-100, and cocktail proteases inhibitors). After centrifugation at 16 000 g for 20 min at 4°C, 80 lL of the cleared lysates was incubated overnight with 10 lL ANTI-FLAG M2
Ò magnetic beads (Sigma) at 4°C. Beads were washed five times with lysis buffer and were resuspended with SDS sample buffer. Total proteins (input corresponding to 20%) and IP proteins on ANTI-FLAG magnetic beads were analyzed by gel electrophoresis and western blotting. The poly(vinylidene difluoride) membrane was incubated with rabbit anti-Gaussia luciferase (NEB, E8023S) as primary antibody and with goat HRP-conjugated anti-rabbit IgG as secondary antibody (Advansta, Menlo Park, CA, USA). The Gluc-tagged UPS proteins were revealed by chemiluminescence using WesternBright TM Sirius TM (Advansta), visualized by a LAS 4000 camera. Band intensities in the IP lanes were normalized according to intensities in the input lanes. For each Gluc-UPS protein, we calculated the IP (E6 or E7)/IP (Ctrl) ratio, where IP (E6 or E7) corresponds to the normalized intensity in the E6 or E7 IP lane and IP (Ctrl) corresponds to the normalized intensity in the control IP lane.
Statistical analysis of the data
Whisker plot representation
Whisker plot representation provides statistical distribution of luminescence values. A box encompassing the lower quartile (Q1), the upper quartile (Q3) and whiskers were shown. Whisker length corresponds to 1.5 times the IQR that is equal to the difference between the upper and lower quartiles (IQR = Q3-Q1). The outliers were defined as values falling above a standard threshold (T) defined by the third quartile (Q3) plus 1.5-fold the IQR, T = Q3 + 1.5(IQR).
KDE plot representation
Kernel density plot representation consists of placing a Gaussian function at each luminescence intensity value (represented on the x-axis) and to sum the contributions of all Gaussian functions to obtain a smooth curve. The curve is then plotted using a log scale for intensity values as described previously (Charpentier and Flachaire. SSNR, 2014, https://doi.org/10.2139/ssrn.2514882). The bandwidth of Gaussian function is considered to be equal to the experimental uncertainty, which was estimated at 25% of the intensity based on data reproducibility. This approach performs well enough as judged by the absence of undersmoothed or oversmoothed aspect in the profiles.
Determination of the confidence interval
To estimate the significance of a NLR value for a given protein-protein pair by comparison to the RRS sampling signal, we calculated a confidence interval for the RRS dataset considering the estimated standard error SE and a confidence level of 99.73% (i.e., a risk a = 0.27%) by using the following expression: l-t.SE AE l + t.SE, where t is the critical value for a two-sided Student's test and for (nÀ1) degrees of freedom. In a first approximation, we considered the NLR value of a protein pair as statistically significantly different from the RRS if its value is above the upper limit of the confidence interval determined for the RRS dataset. 
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